Sera Prognostics News Today

Sera Prognostics, Inc. (NASDAQ:SERA – Get Free Report) CEO Zhenya Lindgardt sold 26,867 shares of the firm’s stock in a transaction on Monday, June 10th. The stock was sold at an average price of $8.11, for a total value of $217,891.37. Following the completion of the transaction, the chief executive officer now owns 869,245 shares […]

SALT LAKE CITY, April 29, 2024 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® , focused on improving maternal and neonatal health by providing innovative pregnancy biomarker...

Marquette Asset Management LLC reduced its holdings in shares of Sera Prognostics, Inc. (NASDAQ:SERA – Free Report) by 9.9% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 32,139 shares of the company’s stock after selling 3,548 shares during the period. Marquette Asset Management LLC’s holdings in Sera Prognostics were worth $192,000 at […]

Acuitas Investments LLC lowered its stake in shares of Sera Prognostics, Inc. (NASDAQ:SERA – Free Report) by 30.0% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 121,258 shares of the company’s stock after selling 51,937 shares during the period. Acuitas […]

CARLSBAD, Calif., April 01, 2024--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced the appointment of veteran industry executive Charlotte Hubbert, Ph.D., as Vice President of Corporate Development. Dr. Hubbert has an extensive background in cell therapy research and venture investment across a broad range of therapeutic modalities and development stages, and has a

Sera Prognostics, Inc. (NASDAQ:SERA – Get Free Report) CEO Zhenya Lindgardt sold 38,899 shares of the business’s stock in a transaction dated Tuesday, March 26th. The shares were sold at an average price of $9.37, for a total transaction of $364,483.63. Following the completion of the transaction, the chief executive officer now owns 908,104 shares […]

Sera Prognostics (NASDAQ:SERA – Get Free Report) will be issuing its quarterly earnings data after the market closes on Wednesday, March 20th. Analysts expect the company to announce earnings of ($0.25) per share for the quarter. Parties interested in registering for the company’s conference call can do so using this link. Sera Prognostics Trading Down […]

Preterm Birth Diagnostic Test Kits MarketOver the next five years, the Preterm Birth Diagnostic Test Kits Market  is predicted to grow at a rate of 1.6 times, with sales projected to reach US$ 121.3 million in 2021. Market growth is anticipated to occur at a compound annual growth rate (CAGR) of 7.6% between 2022 an...

Sera Prognostics, Inc. (NASDAQ:SERA – Get Free Report) General Counsel Benjamin Jackson sold 5,665 shares of the business’s stock in a transaction that occurred on Tuesday, February 6th. The shares were sold at an average price of $8.03, for a total value of $45,489.95. Following the transaction, the general counsel now directly owns 152,035 shares […]

Sera Prognostics, Inc. (NASDAQ:SERA – Get Free Report) shares were up 8% during mid-day trading on Friday . The stock traded as high as $7.74 and last traded at $7.66. Approximately 295,827 shares were traded during trading, an increase of 13% from the average daily volume of 262,132 shares. The stock had previously closed at […]